Cluster of Differentiation as Predictor of Therapy Response to Neoadjuvant Chemotherapy in Advanced Stage Cervical Cancer
Cervical cancer is the third leading cause of death of women worldwide and number one in developing countries. On the Gynecology Division of Oncology Dr. Mohammad Hoesin Hospital Palembang administration of neoadjuvan chemotherapy is used as a therapy in advanced stage cervical cancer. Decreased CD4...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Amber Publication
2018-01-01
|
| Series: | Journal of Research in Medical and Dental Science |
| Subjects: | |
| Online Access: | https://www.jrmds.in/articles/cluster-of-differentiation-as-predictor-of-therapy-response-to-neoadjuvant-chemotherapy-in-advanced-stage-cervical-cance.pdf |